Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–13 of 13 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT07318051
- Conditions
- Adnexal Diseases, Breast Cancer, Breast Diseases, +61 more
- Locations
-
- Natera, Inc. Austin, Texas, United States
NCT06916494
- Conditions
- Muscle Invasive Bladder Cancer
- Locations
-
- First Affiliated Hospital of Chongqing Medical University Chongqing, Chongqing Municipality, China
Not Yet Recruiting
Radical CystEctomy or RaDio-chEMotherapy as Preferred Treatment for invasivE blaDder Cancer
NCT07008833
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +9 more
- Locations
-
- Brazilian Clinical Research Institute São Paulo, Brazil
Not Yet Recruiting
Sasanlimab As Maintenance Treatment Based on Clinical Response to Neoadjuvant Treatment in Molecularly Categorized Muscle Invasive Bladder Cancer Patients
NCT06623162
- Conditions
- MIBC, Muscle Invasive Bladder Cancer
- Locations
-
- Hm Sanchinarro Madrid, Spain
NCT07578233
- Conditions
- Magnetic Resonance Imaging, Multiparametric, Muscle Invasive Bladder Cancer, +2 more
- Locations
-
- Ain Shams University Cairo, Egypt
NCT04053101
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +9 more
- Locations
-
- Centre Hospitalier Universitaire de Bordeaux Bordeaux, France
- Institut Bergonie Bordeaux, France
NCT06807008
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Hematuria, +8 more
- Locations
-
- IRCCS Azienda Ospedaliero-Universitaria di Bologna Bologna, Italy
- AOU Policlinico Umberto I - Sapienza University of Rome Roma, Italy
- Regina Elena" National Cancer Institute Roma, Italy
- Santa Maria della Misericordia University Hospital in Udine Udine, Italy
NCT03773666
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +9 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
NCT03294304
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +9 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Masonic Cancer Center - University of Minnesota Minneapolis, Minnesota, United States
- Huntsman Cancer Institute - University of Utah Health Salt Lake City, Utah, United States
NCT01031420
- Conditions
- High Risk Urothelial Carcinoma of the Upper Urinary Tracts, Muscle Invasive Bladder Cancer, Neoplasms
- Locations
-
- Thomas Jefferson University Hospital Philadelphia, Pennsylvania, United States
- Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
Active, Not Recruiting
Durvalumab+ Gemcitabine/Cisplatin (Neoadjuvant Treatment) and Durvalumab (Adjuvant Treatment) in Patients With MIBC
NCT03732677
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +9 more
- Locations
-
- Research Site Birmingham, Alabama, United States
- Research Site Los Angeles, California, United States
- Research Site Palo Alto, California, United States
- Research Site New Haven, Connecticut, United States
Active, Not Recruiting
Treatment Combination of Durvalumab, Tremelimumab and Enfortumab Vedotin or Durvalumab and Enfortumab Vedotin in Patients With Muscle Invasive Bladder Cancer Ineligible to Cisplatin or Who Refuse Cisplatin
NCT04960709
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +9 more
- Locations
-
- Research Site Orange, California, United States
- Research Site Santa Monica, California, United States
- Research Site New Haven, Connecticut, United States
- Research Site Washington D.C., District of Columbia, United States
Active, Not Recruiting
Open-Label, Randomised, Multi-Drug, Biomarker-Directed, Phase 1b Study in Pts w/ Muscle Invasive Bladder Cancer
NCT02546661
- Conditions
- Muscle Invasive Bladder Cancer
- Locations
-
- Research Site Los Angeles, California, United States
- Research Site New Haven, Connecticut, United States
- Research Site Fort Myers, Florida, United States
- Research Site New York, United States